Home » Authors » Anette Breindl

Anette Breindl

Articles

ARTICLES

NCI initiative aims nanotechnology toward a focus on cancer

Oct. 1, 2004

By Anette Breindl

Intracellular Protein In Membrane Has Potential In Tumor Targeting

Oct. 1, 2004

By Anette Breindl

Bacteria Just Might Receive Bad Taste Of Own Medicine

Sep. 28, 2004

By Anette Breindl

Bacteria Just Might Receive Bad Taste Of Own Medicine

Sep. 28, 2004

By Anette Breindl

Old Approach Provides New Benefits In Dystrophy Model

Sep. 24, 2004

By Anette Breindl

Old Approach Provides New Benefits In Dystrophy Model

Sep. 24, 2004

By Anette Breindl

Multitasking Histone Molecule SAHA Affects Kidney Disease

Sep. 22, 2004

By Anette Breindl

Multitasking Histone Molecule SAHA Affects Kidney Disease

Sep. 22, 2004

By Anette Breindl

Serendipitous Double Knockout Sheds Light On Brain Chemistry

Sep. 20, 2004

By Anette Breindl

Serendipitous Double Knockout Sheds Light On Brain Chemistry

Sep. 20, 2004

By Anette Breindl

View All Articles by Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...